 |
|
Effect of Alcohol Intake on Human Apolipoprotein A-I—Containing Lipoprotein Subfractions
Pascal Puchois;
Nordine Ghalim;
Gêcel Zylberberg;
Pierre Fievet;
Catherine Demarquilly;
Jean Charles Fruchart
Arch Intern Med. 1990;150(8):1638-1641.
Abstract
High-density lipoprotein comprises two main types of lipoprotein particles: (1) those that contain apolipoproteins A-I and A-II, designated LpA-I:A-II, and (2) those that contain apolipoprotein A-I but not apolipoprotein A-II, designated LpA-I. Both have been extensively studied and are believed to represent distinct metabolic entities that may confer differing protection against coronary artery disease risk. We have previously suggested that LpA-I might represent the antiatherogenic effect, which has been ascribed mainly to its effect on high-density lipoprotein cholesterol; we set out to investigate, in 344 men, the relation between LpA-I:A-II and LpA-I levels and alcohol consumption. As the alcohol intake rose, LpA-I:A-IIII levels increased, while LpA-I levels fell. On the assumption that LpA-I is the antiatherogenic fraction of high-density lipoprotein, the putative protective action of alcohol consumption against coronary artery disease should be reconsidered.
(Arch Intern Med. 1990;150:1638-1641)
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Type of Alcoholic Beverage and Cardiovascular Disease - Does it Matter?
Gronbaek
European Journal of Cardiovascular Prevention & Rehabilitation 2003;10:5-10.
ABSTRACT
Commentary: Alcohol, coronary heart disease and public health: which evidence-based policy
Bovet and Paccaud
Int J Epidemiol 2001;30:734-737.
FULL TEXT
Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors
Rimm et al.
BMJ 1999;319:1523-1528.
ABSTRACT
| FULL TEXT
Patient-Directed, Nonprescription Approaches to Cardiovascular Disease
Simon
Arch Intern Med 1994;154:2283-2296.
ABSTRACT
Low Levels of High-Density Lipoprotein Cholesterol (Hypoalphalipoproteinemia) An Approach to Management
Rosenson
Arch Intern Med 1993;153:1528-1538.
ABSTRACT
A Votre Sante
Kreisberg
Arch Intern Med 1992;152:263-265.
ABSTRACT
|
